AHA white paper calls HIT 'common fiber' for improved care quality

The American Hospital Association's (AHA) new white paper outlines how the use of health IT can improve quality across the care continuum.

The paper focuses on care coordination and transition management; new and emerging healthcare models; patient and family care; and team-based care. It also offers resources related to workforce-specific roles, responsibilities and technologies to help hospitals transition to value-based care delivery models.

Health IT will drive quality care as "the common fiber that supports" the paper's four focus areas.

"Technology has--and will continue to have--a huge impact on the transition of care delivery and the associated workforce roles and responsibilities," according to the paper. Ongoing evaluations of health IT and how it affects different care models will be necessary to continue innovation in the healthcare industry.

The push for EHR interoperability will continue, according to the organization. "Interoperable health information systems are key to configuring service delivery in new and emerging care coordination models. The EHR is an important tool to advance the quality of communication and information exchange across provider systems and to improve health outcomes."

Meaningful Use will be a primary driver in advancing widespread adoption of interoperable technologies. "To be optimally effective, EHRs require broad adoption, practitioners must pay constant attention to data entry to minimize errors and care coordination patterns have to be reengineered to accommodate EHR usage."

Read the complete white paper. 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.